“The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition”. SKIN The Journal of Cutaneous Medicine 9, no. 5 (September 7, 2025): 2669–2673. Accessed November 6, 2025. https://skin.dermsquared.com/skin/article/view/3446.